Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
Completed
AstraZeneca
Phase 2
2013-01-01
The purpose of this study is to determine if the study drug is safe, tolerable and active in
reducing fluid overload/weight gain between dialysis sessions for patients with End Stage
Renal Disease on Hemodialysis.
Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
Completed
Ardelyx
Phase 2
2013-01-01
The purpose of this study is to determine if the study drug is safe, tolerable and active in
reducing fluid overload/weight gain between dialysis sessions for patients with End Stage
Renal Disease on Hemodialysis.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
Completed
AstraZeneca
Phase 1
2013-07-01
The study is designed to evaluate the safety, tolerability, pharmacodynamics and
pharmacokinetics of AZD1722 in healthy Japanese subjects at increasing doses given for 7 days
in order to allow for including Japanese subjects in future global studies. A cohort of
Caucasian subjects will be included in the study to evaluate cardiac effects, assessed by
digital ECGs (dECG) recordings, also in Caucasian subjects.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
Completed
Ardelyx
Phase 1
2013-07-01
The study is designed to evaluate the safety, tolerability, pharmacodynamics and
pharmacokinetics of AZD1722 in healthy Japanese subjects at increasing doses given for 7 days
in order to allow for including Japanese subjects in future global studies. A cohort of
Caucasian subjects will be included in the study to evaluate cardiac effects, assessed by
digital ECGs (dECG) recordings, also in Caucasian subjects.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
